The first-in-human SCS trial saw all three SMA patients able to increase their walking distance within six minutes to 20 meters.

From FDA approvals to medical milestones, here are four key developments from spine and orthopedic medtech companies since Jan. 29.

The spinal surgical robots market is experiencing rapid growth as healthcare facilities worldwide adopt robotic-assisted technologies for spine surgeries. These robots enhance precision, reduce ...

The global spine biologics market is on pace to have a 17.51% compound annual growth rate from 2024 to 2034, according to a Jan. 31 news release from Researchan ...

The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at ...

Medtronic (NYSE: MDT) today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord stimulator (CL-SCS).

Medtronic is capturing demand for its cutting-edge solutions, as recent product launches emerge to drive new growth. With the ...

Introduction to Wearable Artificial OrgansThe field of wearable artificial organs (WAOs) is a game-changer in modern medicine, offering innovative solutions that replicate the functions of human ...

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Medtronic has inked a five-year deal to sell Kuros Biosciences’ MagnetOs bone graft technology for use in spine procedures in the U.S. Kuros, which disclosed the agreement Tuesday, developed ...

We recently compiled a list of the Blackrock's 30 Most Important AI Stocks. In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against the other AI stocks. In the ...

Intuitive Surgical will face competition this year from Medtronic and smaller companies like CMR Surgical and Moon Surgical ...